These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 11745739)
1. Limited phase I study of morphine-3-glucuronide. Penson RT; Joel SP; Clark S; Gloyne A; Slevin ML J Pharm Sci; 2001 Nov; 90(11):1810-6. PubMed ID: 11745739 [TBL] [Abstract][Full Text] [Related]
2. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide. Penson RT; Joel SP; Roberts M; Gloyne A; Beckwith S; Slevin ML Br J Clin Pharmacol; 2002 Apr; 53(4):347-54. PubMed ID: 11966664 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. Meineke I; Freudenthaler S; Hofmann U; Schaeffeler E; Mikus G; Schwab M; Prange HW; Gleiter CH; Brockmöller J Br J Clin Pharmacol; 2002 Dec; 54(6):592-603. PubMed ID: 12492606 [TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine. Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775 [TBL] [Abstract][Full Text] [Related]
5. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions. Barrett DA; Barker DP; Rutter N; Pawula M; Shaw PN Br J Clin Pharmacol; 1996 Jun; 41(6):531-7. PubMed ID: 8799518 [TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain. Quigley C; Joel S; Patel N; Baksh A; Slevin M Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850 [TBL] [Abstract][Full Text] [Related]
7. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. Bouwmeester NJ; Anderson BJ; Tibboel D; Holford NH Br J Anaesth; 2004 Feb; 92(2):208-17. PubMed ID: 14722170 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis. Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468 [TBL] [Abstract][Full Text] [Related]
9. Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine. Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA J Pharmacol Exp Ther; 1997 Aug; 282(2):779-86. PubMed ID: 9262341 [TBL] [Abstract][Full Text] [Related]
10. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Hasselström J; Säwe J Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060 [TBL] [Abstract][Full Text] [Related]
11. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep. Milne RW; Sloan PA; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA Drug Metab Dispos; 1993; 21(6):1151-6. PubMed ID: 7905398 [TBL] [Abstract][Full Text] [Related]
12. Randomized placebo-controlled trial of the activity of the morphine glucuronides. Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027 [TBL] [Abstract][Full Text] [Related]
13. Itraconazole, a potent inhibitor of P-glycoprotein, moderately increases plasma concentrations of oral morphine. Heiskanen T; Backman JT; Neuvonen M; Kontinen VK; Neuvonen PJ; Kalso E Acta Anaesthesiol Scand; 2008 Nov; 52(10):1319-26. PubMed ID: 19025521 [TBL] [Abstract][Full Text] [Related]
14. Comparative disposition of morphine-3-glucuronide during separate intravenous infusions of morphine and morphine-3-glucuronide in sheep. Importance of the kidney. Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA Drug Metab Dispos; 1995 Mar; 23(3):334-42. PubMed ID: 7628298 [TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine. Somogyi AA; Nation RL; Olweny C; Tsirgiotis P; van Crugten J; Milne RW; Cleary JF; Danz C; Bochner F Clin Pharmacokinet; 1993 May; 24(5):413-20. PubMed ID: 8504624 [TBL] [Abstract][Full Text] [Related]
16. Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide. de Hoogd S; Välitalo PAJ; Dahan A; van Kralingen S; Coughtrie MMW; van Dongen EPA; van Ramshorst B; Knibbe CAJ Clin Pharmacokinet; 2017 Dec; 56(12):1577-1587. PubMed ID: 28510797 [TBL] [Abstract][Full Text] [Related]